The firm currently has an "overweight" rating on the stock. JPMorgan Cazenove's target price would suggest a potential upside of 27.31% from the stock's previous close.
http://www.americanbankingnews.com/2013/08/07/vitamin-shoppe-price-target-cut-to-55-00-vsi/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29
http://www.americanbankingnews.com/2013/08/07/vitamin-shoppe-price-target-cut-to-55-00-vsi/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+AmericanBankingNews+%28American+Banking+News%29
No comments:
Post a Comment